IR-Med
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IR-Med generated cash of -$3,232,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,000,000 last year. Net change in cash is therefore -$2,235,000.

Cash Flow

IR-Med Inc. (OTC:IRME): Cash Flow
2019 -72K -227.76K 300K
2020 -402K 0 2.03M
2021 -2.48M -61K 3.49M
2022 -3.37M -59K 3.62M
2023 -3.23M -2K 1M

IRME Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
3.00M2.81M1.86M235K234.76K
Operating activities
Net income
-4.90M-4.73M-3.71M-752K-248K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
17K10K5K1K2K
Stock-based compensation expense
1.68M1.33M1.33M25K0
Deferred income tax benefit 1.68M1.33M1.33M25K0
Changes in operating assets and liabilities:
Accounts receivable, net
-25K12K-38K-16K-7K
Inventories
0-35K83K-320K-37
Accounts payable
6K35K-83K320K124K
Cash generated by operating activities
-3.23M-3.37M-2.48M-402K-72K
Investing activities
Purchases Of Investments
0-9K-30K00
Investments In Property Plant And Equipment
-2K-50K-31K00
Acquisitions Net
00000
Cash generated by investing activities
-2K-59K-61K0-227.76K
Financing activities
Common Stock Issued
1M3.62M3.49M2.03M300K
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
00000
Cash used in financing activities
1M3.62M3.49M2.03M300K
Net Change In Cash
-2.23M187K949K1.63M235
Cash at end of period
767K3.00M2.81M1.86M235K
Data sourceData sourceData source